{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:04:13Z","timestamp":1788991453844,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12890-018-0732-3","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T08:55:43Z","timestamp":1542617743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-4409","authenticated-orcid":false,"given":"C.","family":"Addy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,19]]},"reference":[{"key":"732_CR1","doi-asserted-by":"publisher","first-page":"197950","DOI":"10.1155\/2015\/197950","volume":"2015","author":"G Bonaiti","year":"2015","unstructured":"Bonaiti G, Pesci A, Marruchella A, et al. Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis. BioMed Res Int. 2015;2015:197950. \n                    https:\/\/doi.org\/10.1155\/2015\/197950\n                    \n                  .","journal-title":"BioMed Res Int"},{"key":"732_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/1471-2458-10-612","volume":"10","author":"J Moore","year":"2010","unstructured":"Moore J, Kruijsharr M, Ormerod LP, et al. Increasing reports on non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995\u20132006. BMC Public Health. 2010;10:612.","journal-title":"BMC Public Health"},{"issue":"4","key":"732_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"732_CR4","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","volume":"71","author":"RA Floto","year":"2016","unstructured":"Floto RA, Olivier KN, L. Saiman et al.US Cystic Fibrosis Foundation and European cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71:i1\u2013i22.","journal-title":"Thorax"},{"issue":"Suppl 2","key":"732_CR5","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"Charles S Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T, et al. British Thoracic Society Guidelines for the Diagnosis and Management of Non-Tuberculous Mycobacterial Pulmonary Disease (NTM-PD). Thorax. 2017;72(Suppl.2).","journal-title":"Thorax"},{"key":"732_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cid\/ciq237","volume":"52","author":"J Jarand","year":"2011","unstructured":"Jarand J, Levin A, Zhang L, et al. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis. 2011;52:565\u201371.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"732_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1378\/chest.102.2.647","volume":"102","author":"E Tanaka","year":"1992","unstructured":"Tanaka E, Tada K, Amitani R, et al. Systemic hypersensitivity Vasculitis associated bronchiectasis. Chest. 1992;102(2):647\u20139.","journal-title":"Chest"},{"key":"732_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/pgmj.71.831.24","volume":"71","author":"IN Bruce","year":"1995","unstructured":"Bruce IN, McAteer JA, Gardiner PV, et al. Chronic supprative lung disease with associated vasculitis. Postgrad Med J. 1995;71:24\u20137.","journal-title":"Postgrad Med J"},{"key":"732_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2466-12-47","volume":"12","author":"SK Tagboto","year":"2012","unstructured":"Tagboto SK, Venkatesh AG. Progressive dyspnoea following the treatment of Mycobacterium abscessus infection in an individual with relapsing granulomatosis with polyangiitis (Wegener\u2019s), complicated by hearing loss requiring cochlear implantation. BMC Pulm Med. 2012;12:47.","journal-title":"BMC Pulm Med"},{"key":"732_CR10","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2169\/internalmedicine.55.6588","volume":"55","author":"S Asano","year":"2016","unstructured":"Asano S, Mizuno S, Okachiet S, et al. Antineutrophil cytoplasmic antibody-associated Vasculitis superimposed on infection-related glomerulonephritis secondary to pulmonary Mycobacterium avium complex infection. Intern Med. 2016;55:2439\u201345.","journal-title":"Intern Med"},{"issue":"2","key":"732_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1525-1470.2012.01856.x","volume":"31","author":"S Filiz","year":"2014","unstructured":"Filiz S, Kocacik Uygun DF, Verhard EM, et al. Cutaneous Leukocytoclastic Vasculitis due to Salmonella enteritidis in a child with Interleukin-12 receptor Beta-1 deficiency. Paediatr Dermatol. 2014;31(2):236\u201340.","journal-title":"Paediatr Dermatol"},{"issue":"6","key":"732_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cid\/cit809","volume":"58","author":"CA Czaja","year":"2014","unstructured":"Czaja CA, Merkel PA, Chan ED, et al. Rituximab as Successful Adjunct Treatment in a Patient With Disseminated Nontuberculous Mycobacterial Infection Due to Acquired Anti\u2013Interferon-\u03b3 Autoantibody. Clin Infect Dis. 2014;58(6):115\u20138.","journal-title":"Clin Infect Dis"},{"key":"732_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","volume":"15","author":"U-I Wu","year":"2015","unstructured":"Wu U-I, Holland SM. Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis. 2015;15:968\u201380.","journal-title":"Lancet Infect Dis"},{"key":"732_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.micinf.2005.10.029","volume":"8","author":"MH Haverkamp","year":"2006","unstructured":"Haverkamp MH, Van Diesel JT, Holland SM. Human host genetic factors in nontuberculous mycobacterial infection; lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-\u03b3-dependent signalling. Microbes Infect. 2006;8:1157\u201366.","journal-title":"Microbes Infect"},{"key":"732_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2334-8-17","volume":"8","author":"MT Milan\u00e9s-Virelles","year":"2008","unstructured":"Milan\u00e9s-Virelles MT, Garc\u00eda-Garc\u00eda I, Santos-Herrera Y, et al. Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double blind,placebo-controlled study. BMC Infect Dis. 2008;8:17.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"732_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/archderm.135.2.125","volume":"135","author":"A Colsky","year":"1999","unstructured":"Colsky A, Hanly A, Elgart G, Kerdel F. Treatment of Refractory Disseminated Mycobacterium abscessus Infection With Interferon Gamma Therapy. Arch Dermatol. 1999;135(2):125\u20137.","journal-title":"Arch Dermatol"},{"key":"732_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.7326\/0003-4819-123-3-199508010-00009","volume":"123","author":"JI Gallin","year":"1995","unstructured":"Gallin JI, Farber JM, Holland SM. Interferon-y in the Management of Infectious Diseases. Ann Intern Med. 1995;123:216\u201324.","journal-title":"Ann Intern Med"},{"issue":"2","key":"732_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/IPC.0b013e3181f744bb","volume":"19","author":"R Rivera","year":"2011","unstructured":"Rivera R, Alrabaa S, List A, Greene J. Successful Treatment of Refractory Disseminated Mycobacterium abscessus Infection Using Interferon Gamma. Infect Dis Clin Prac. 2011;19(2):142\u20135.","journal-title":"Infect Dis Clin Prac"},{"issue":"17","key":"732_CR19","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","volume":"119","author":"SK Browne","year":"2012","unstructured":"Browne SK, Zaman R, Sampaio E, et al. Anti-CD20 (rituximab) therapy for anti\u2013IFN autoantibody\u2013associated nontuberculous mycobacterial infection. Blood. 2012;119(17):3933\u20139.","journal-title":"Blood"},{"key":"732_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.clim.2010.07.011","volume":"137","author":"A Lim","year":"2017","unstructured":"Lim A, Allison C, Price P, et al. Susceptibility to pulmonary disease due to mycobacterial avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than TH1 deficiency. Clin Immunol. 2017;137:296\u2013320.","journal-title":"Clin Immunol"},{"issue":"5","key":"732_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1164\/rccm.201502-0387OC","volume":"192","author":"E Szymanski","year":"2015","unstructured":"Szymanski E, Leung JM, Fowler CJ, et al. Pulmonary nontuberculous mycobacterial infection: a multisystem, Multigenic Disease. Am J Respir Crit Care Med. 2015;192(5):618\u201328.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"732_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccm.2014.11.002","volume":"36","author":"E Henkle","year":"2015","unstructured":"Henkle E, Winthrop K. Nontubercuolous mycobacteria infections in immunocompromised hosts. Clin Chest Med. 2015;36(1):91\u20139.","journal-title":"Clin Chest Med"},{"key":"732_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/annrheumdis-2011-200690","volume":"72","author":"KL Winthrop","year":"2013","unstructured":"Winthrop KL, Baxter R, Liu L. Mycobacterial diseases and anti-tumour necrosis factor therapy in USA. Ann Rheum Dis. 2013;72:37\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"732_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2174\/157015911796557939","volume":"9","author":"EC Lallana","year":"2011","unstructured":"Lallana EC, Fadul CE. Toxicities of immunosuppressive treatment of autoimmune neurologic diseases. Curr Neuropharmacol. 2011;9(3):468\u201377.","journal-title":"Curr Neuropharmacol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0732-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-018-0732-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0732-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T19:06:16Z","timestamp":1574103976000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-018-0732-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/s12890-018-0732-3","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,19]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors represent the complexity in managing this case across multiple hospital sites and specialities. Respiratory speciality input has been provided both at Belfast City Hospital, Belfast (CA, GD, SC and DGD) and at Royal Brompton and Harefield Hospital London (AJ) with Rheumatology specialist input provided at Musgrave Hospital, Belfast (GW).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"170"}}